Enter valid email.
POSTED: March 22, 2017
Dr. Daniel Petrylak talks about how doctors may begin to use biomarkers to help guide treatment.
Not a member? Join us!
Tags: Chemotherapy, daniel petrylak, Hormonal Therapy, prostate cancer, prostate cancer information, Uncategorized, xtandi prostate, zytiga prostate,
Posted: Mar 22, 2017
I have seen several of these articles in recent issues concerning molecular profiling for PC treatment decisions. Being very interested in having my PC profiled because of my condition I always contact the speaker or writer of the articles. I have yet to hear back from one of them which is really frustrating. It is not worth having this information if, as patients, we cant get anything done about it! What am I doing wrong?. should I be starting with my oncologist? most drs. I have talked to about this are not well informed. any advice is greatly appreciated.
Posted: Nov 01, 2018
Posted: Dec 10, 2018